The purpose of this study is to understand if there are core differences present in the brain imaging scans of a fetus who has a limb difference. These imaging scans will be completed before and after the birth of the child. This study will also allow us to counsel families and provide education on the specified limb difference.

I will study how many practices use Transitional Care Management or Chronic Care Management billing codes over time, and how these billing codes affect patient outcomes such as readmissions and emergency visits. In addition, I will interview practices as to why they choose to use or not use these billing codes.

To adapt and initially test an established physical activity promotion intervention for use in adult supervised care (e.g., adult care homes, day cares).

Recent studies have suggested that previously unknown proteins found in human blood could be involved in certain auto-immune conditions. The purpose of this research study is to investigate the presence (or absence) of these proteins in blood from patients with SLE. Identifying new proteins involved in the SLE disease process could provide a new molecular model for auto-immune disorders and eventually lead to new diagnostic tools and/or new therapies.

The purpose of this study is to collected and store sinonasal tissue obtained during sinus surgery that would otherwise be discarded as medical waste. This tissue will be critical in future research projects investigating chronic sinusitis.

The purpose of this expanded access IND (compassionate use) program is to provide tecovirimat for treatment or prevention of non-variola orthopoxvirus infections (e.g., vaccinia, monkeypox, cowpox or other human virus infection identified as an orthopoxvirus) and secondary treatment of complications from replication-competent vaccinia vaccine in adults and children.

The purpose of the study is to understand why it is the case that authors do not submit reproducible research compendia even when a policy requires it (and policy guidance explains how). To do so, the study looks toward the specific mechanisms that inhibit and/or facilitate execution of data management tasks that support reproducibility. Identifying these mechanisms can inform the design of interventions that better equip researchers to produce and share high-quality research compendia. Such interventions may reduce the amount of time and labor currently required for current data verification workflows, which in turn may make journal-based data policies more feasible for a greater number of journals.

You are being asked to take part in this study because you previously agreed to receive a U.S. Food and Drug Administration (FDA) approved drug, idecabtagene vicleucel (ide-cel), for the treatment of your disease as part of routine care and not a clinical research study. You had the blood collection (leukapheresis) (pronounced loo-ka-fer-ee-sis) procedure, your T cells (a subset of your white blood cells that are part of your immune system and attack things like infections and cancer cells) were collected and genetically modified in a laboratory in order to manufacture the ide-cel T cells for your disease treatment. The ide-cel T cells that were produced do not meet all of the prespecified release criteria to be used as a routine prescription drug as required by the governing health authority (such as the FDA) where you are being treated. For example, the modified T cells may have a lower cell

The CMR is a population based breast imaging registry for women screened for breast cancer in NC.

We are reaching out to patients who were hospitalized at UNC and are also eligible for cardiac rehabilitation. We want to learn more about what the barriers are to attending cardiac rehabilitation. Did you not know it existed? Did the time commitment seem too much? What other questions did you have?